FDA.reportPublic FDA data

Alphanate (expressed as von Willebrand factor) 1 UNT Injection

RxCUI
1661345
RxNorm name
Alphanate (expressed as von Willebrand factor) 1 UNT Injection
Display name
Alphanate (expressed as von Willebrand factor) 1 UNT Injection
Full name
Alphanate (expressed as von Willebrand factor) 1 UNT Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
102475AlphanateAntihemophilic Factor/von Willebrand Factor Complex (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5a7aea94-654c-4113-9014-c3137de0a931Alphanate (expressed as von Willebrand factor) 1 UNT Injection [PSN] · factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection [Alphanate] [SBD] · Alphanate (expressed as von Willebrand factor) 1 UNT Injection [SY]326These highlights do not include all the information needed to use ALPHANATE safely and effectively. See full prescribing information for ALPHANATE. ALPHANATE (ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX [HUMAN]) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 197820250522